PHOTONIC TUMOR THERAPY
Clinical Service in Internventional Oncology
logo pdt

Efficacy


Clinical Efficacy


Sweden/University Hospital Lund

Prof. K. SVANBERG, MD

basal cell carcinoma:

75 % remission

no side effects


Austria/Rudolfstiftung Vienna

Prof. W. GRÜNBERGER, MD

cervical dysplasia:

80 % remission

no side effects


Austria/Medical University Vienna

Prof. H. HÖNIGSMANN, MD

actinic keratosis:

100 % clinical response

250 % higher tolerability (p<0.0001)

no side effects


Austria/Medical University Innsbruck

Prof. W. VOGEL, MD

cholangiocarcinoma,

Klatskin, 

esophageal cancer,

Barrett’s,

colorectal cancer:

> 90 % clinical response:

shrinkage of tumor mass, size

reduction of degree of stenosis

50 % without post-procedural stenting

20 % cholangitis without any mortality

15,8 months (12,9 - 18,1) median survival with QoL

0,03 % sunburn/grade 1

0 % procedure related mortality

Procedure Efficacy: Bile duct

  Chemotherapy*
PHOTONIC
TUMOR
THERAPY
Efficacy
Advantage
   REIMBURSED REIMBURSED
Cost
6.140,00 5.140,00 120
Clinical response
%
 9,5 >90 947
Median Survival
m
6,5 18,5 285
   RF-Ablation*
Mucosectomy*
PHOTONIC
TUMOR
THERAPY
  REIMBURSED REIMBURSED REIMBURSED
Number of Procedures required
3 - 4 2 - 3 1
Cost Procedure
 9.000,00 750,00 5.140,00
Cost Hospitalization
7.500,00 6.250,00 1.000,00
Cost Over all
16.500,00 7.000,00 6.140,00
Cost Disadvantage
%
268 114 0
* ... Figures: Presentation at the
       10th World Congress OESO - World Organization for Specialized Studies on Diseases of the Eosphagus, Boston, USA, August 28-31, 2010
        by G. HOFMANN, COO PHOTO DYNAMIC THERAPY LLC, Vienna, Austria
* ... Figures: Awarded Presentation at the
        EURECAN European Venture Contest 2010, Healthcare, Aarhus, Denmark, 7 September 2010
        by G. HOFMANN, COO PHOTO DYNAMIC THERAPY LLC, Vienna, Austria

Procedure Efficacy: Esophagus